Optimisation of oral anticoagulants for patients with atrial fibrillation within 12â¯months after percutaneous coronary intervention: A <i>meta</i>-analysis and systematic review.

Wang, Shuo; Liu, Ying; Wang, Linxin; Zuo, Haiqi; Tian, Yanfeng; Wang, Yimeng; Yin, Dechun; Zhang, Haiyu; Tian, Ye

Optimisation of oral anticoagulants for patients with atrial fibrillation within 12â¯months after percutaneous coronary intervention: A meta-analysis and systematic review.

Wang, Shuo; Liu, Ying; Wang, Linxin; Zuo, Haiqi; Tian, Yanfeng; Wang, Yimeng; Yin, Dechun; Zhang, Haiyu; Tian, Ye.

Afiliação

Wang S; Department of Pathophysiology and Key Laboratory of Cardiovascular Pathophysiology, Harbin Medical University, Key Laboratory of Cardiovascular Research (Harbin Medical University), Ministry of Education, Harbin 150086, PR China.
Liu Y; Heilongjiang Academy of Medical Sciences, Harbin, China.
Wang L; Heilongjiang Academy of Medical Sciences, Harbin, China.
Zuo H; Department of Cardiology, The First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin 150001, PR China.
Tian Y; Heilongjiang Academy of Medical Sciences, Harbin, China.
Wang Y; Department of Cardiology, The First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin 150001, PR China.
Yin D; Heilongjiang Academy of Medical Sciences, Harbin, China.
Zhang H; Department of Cardiology, The First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin 150001, PR China.
Tian Y; Department of Cardiology, The First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin 150001, PR China.

Int J Cardiol Heart Vasc ; 36: 100850, 2021 Oct.

Article em En | MEDLINE | ID: mdl-34401468

Palavras-chave

95% CI, 95% confidence intervals; AF, Atrial fibrillation; Antithrombotic therapy; Atrial fibrillation; DAT, Oral anticoagulants plus single antiplatelet therapy; IIa, Factor IIa; ISTH, International Society on Thrombosis and Hemostasis; MI, Myocardial infarction; NOACs, Novel oral anticoagulants; OACs, Oral anticoagulants; Oral anticoagulant; PCI, Percutaneous coronary intervention; Percutaneous coronary intervention; RR, Risk ratios; SD, Standard deviation; SUCRA, Surface under the cumulative ranking curve; TAT, Vitamin K antagonist plus a P2Y12 inhibitor and aspirin; TIMI, Thrombolysis In Myocardial Infarction; VKA, Vitamin K antagonist; Xa, Factor Xa

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Idioma: En Revista: Int J Cardiol Heart Vasc Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google